163 related articles for article (PubMed ID: 31512743)
1. A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm.
Billey C; Billet S; Robic MA; Cognet T; Guillaume M; Vinel JP; Péron JM; Lairez O; Bureau C
Hepatology; 2019 Dec; 70(6):1928-1941. PubMed ID: 31512743
[TBL] [Abstract][Full Text] [Related]
2. Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.
Schneider H; Berliner D; Stockhoff L; Reincke M; Mauz JB; Meyer B; Bauersachs J; Wedemeyer H; Wacker F; Bettinger D; Hinrichs JB; Maasoumy B
United European Gastroenterol J; 2023 Nov; 11(9):837-851. PubMed ID: 37897707
[TBL] [Abstract][Full Text] [Related]
3. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction.
Filì D; Falletta C; Luca A; Hernandez Baravoglia C; Clemenza F; Miraglia R; Scardulla C; Tuzzolino F; Vizzini G; Gridelli B; Bosch J
Dig Liver Dis; 2015 Dec; 47(12):1052-8. PubMed ID: 26427586
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic response in cirrhotic patients with transjugular intrahepatic portosystemic shunt].
Wang JF; Ma JQ; Luo JJ; Chen HY; Mi SL; Chen SY; Su YG; Ge JB
Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):700-705. PubMed ID: 32838501
[No Abstract] [Full Text] [Related]
5. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
[TBL] [Abstract][Full Text] [Related]
6. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
[TBL] [Abstract][Full Text] [Related]
7. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.
Rabie RN; Cazzaniga M; Salerno F; Wong F
Am J Gastroenterol; 2009 Oct; 104(10):2458-66. PubMed ID: 19532126
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt.
Radunski UK; Kluwe J; Klein M; Galante A; Lund GK; Sinning C; Bohnen S; Tahir E; Starekova J; Bannas P; Stehning C; Adam G; Lohse AW; Blankenberg S; Muellerleile K; Benten D
Sci Rep; 2021 Jun; 11(1):12719. PubMed ID: 34135410
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic Heart Failure After Transjugular Intrahepatic Portosystemic Shunt Placement: Incidence, Outcomes, and Predictors.
Modha K; Kapoor B; Lopez R; Sands MJ; Carey W
Cardiovasc Intervent Radiol; 2018 Apr; 41(4):564-571. PubMed ID: 29181605
[TBL] [Abstract][Full Text] [Related]
11. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
12. Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis.
Gumauskienė B; Krivickienė A; Jonkaitienė R; Vaškelytė JJ; Siudikas A; Ereminienė E
Medicina (Kaunas); 2018 Sep; 54(4):. PubMed ID: 30344294
[No Abstract] [Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters.
Pudil R; Praus R; Hulek P; Safka V; Fejfar T; Vasatova M; Jirkovsky V
Ann Hepatol; 2013; 12(3):464-70. PubMed ID: 23619264
[TBL] [Abstract][Full Text] [Related]
14. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
16. The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.
Saugel B; Mair S; Meidert AS; Phillip V; Messer M; Nennstiel S; Berger H; Gaa J; Wagner JY; Schneider H; Schmid RM; Huber W
J Crit Care; 2014 Dec; 29(6):1001-5. PubMed ID: 25220530
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
20. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
Cemri M; Arslan U; Kocaman SA; Cengel A
J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
